The EPS projection of Illumina, Inc. (NASDAQ:ILMN) for period quarter completed 2016-12-31 is $0.9.
The EPS estimates given a week and 30-days ago were $0.9 and $0.9 correspondingly. This number 60 and 90 days before was $0.9 and $0.9 respectively. However, over last week ago, the change in EPS estimate is -0.14%.
For the quarter completed 2 mean estimate is $0.9 based on 11 EPS estimations. As on 2016-07-26 estimated EPS stood at $0.86 showing surprise of $0.13, or 17.81%. Following the disclosed forecasts, the standard deviation is $0.01.
The upgrade in EPS revisions were 0 a week earlier against negative revisions of 7. In last 1- month and 60-days, the upgrade in EPS revisions were 0 and 0 correspondingly, whereas for a quarter and 120-days earlier, it was 0 and 0 in that sequence.
The negative revisions of earnings per-share in the last 1-month and 60-days were 7 and 7 in that order. However, a quarter and 120-days earlier, this count was 8 and 8 correspondingly.
EPS revisions downgrade and upgrade in the last 18 days were 7 and 1, correspondingly.
Quarterly Sales Estimates
The arithmetic mean of apparent annual sales of Illumina, Inc. (NASDAQ:ILMN) is $646.547 and the median is $643.595. The estimate is stated by 4 analysts for the fiscal 2016.
The highest yearly projection is $689 and lowest sales mark is $610. This results a standard deviation of $40.936.
Almost 4 have revised sales target positively in the past week and 4 have downgraded forecasts. Depending on the stated estimates, the calculated change in target against the past week is -5.234%.
Nearly 4 revised sales projections positively over the past month and 4 have downgraded forecasts. It leads to a mean estimate deviation of -4.999%.
Just about 4 have revised sales forecast positively over the quarter and 4 have downgraded forecasts, giving a deviation of -4.866%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...